Papers
Topics
Authors
Recent
Search
2000 character limit reached

Rebound in epidemic control: How misaligned vaccination timing amplifies infection peaks

Published 27 May 2024 in physics.soc-ph and q-bio.PE | (2405.17189v1)

Abstract: In this study, we explore the dynamic interplay between the timing of vaccination campaigns and the trajectory of disease spread in a population. Through comprehensive data analysis and modeling, we have uncovered a counter-intuitive phenomenon: initiating a vaccination process at an inopportune moment can paradoxically result in a more pronounced second peak of infections. This "rebound" phenomenon challenges the conventional understanding of vaccination impacts on epidemic dynamics. We provide a detailed examination of how improperly timed vaccination efforts can inadvertently reduce the overall immunity level in a population, considering both natural and vaccine-induced immunity. Our findings reveal that such a decrease in population-wide immunity can lead to a delayed, yet more severe, resurgence of cases. This study not only adds a critical dimension to our understanding of vaccination strategies in controlling pandemics but also underscores the necessity for strategically timed interventions to optimize public health outcomes. Furthermore, we compute which vaccination strategies are optimal for a COVID-19 tailored mathematical model, and find that there are two types of optimal strategies. The first type prioritizes vaccinating early and rapidly to reduce the number of deaths, while the second type acts later and more slowly to reduce the number of cases; both of them target primarily the elderly population. Our results hold significant implications for the formulation of vaccination policies, particularly in the context of rapidly evolving infectious diseases.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (40)
  1. Cross-country effects and policy responses to COVID-19 in 2020: The Nordic countries. Economic Analysis and Policy, 71:198–210, 2021.
  2. Martin C. J. Bootsma and Neil M. Ferguson. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proceedings of the National Academy of Sciences USA, 104(18):7588–7593, 2007.
  3. Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries. Frontiers in Immunology, 14:1151311, 2023.
  4. Modeling infectious diseases in humans and animals. Princeton University Press, Princeton, 2008.
  5. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet Infectious Diseases, 20(5):553–558, 2020.
  6. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nature Medicine, 26(6):855–860, 2020.
  7. Multiple Epidemic Wave Model of the COVID-19 Pandemic: Modeling Study. Journal of Medical Internet Research, 22(7):e20912, 2020.
  8. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in china. Science, 368(6492):742–746, 2020.
  9. Modeling the spatiotemporal epidemic spreading of COVID-19 and the impact of mobility and social distancing interventions. Physical Review X, 10:041055, 2020.
  10. Modeling COVID-19 dynamics in illinois under nonpharmaceutical interventions. Physical Review X, 10(4):041033, 2020.
  11. Predictive mathematical models of the COVID-19 pandemic: underlying principles and value of projections. JAMA, 323(19):1893–1894, 2020.
  12. Modelling COVID-19. Nature Reviews Physics, 2(6):279–281, 2020.
  13. Potential benefits of delaying the second mRNA COVID-19 vaccine dose. arXiv:2102.13600 [physics, q-bio], 2021.
  14. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study. The Lancet Infectious Diseases, 21(8):1097–1106, 2021.
  15. SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status. Nature Communications, 13(1):2777, 2022.
  16. Optimizing infectious disease interventions during an emerging epidemic. Proceedings of the National Academy of Sciences USA, 107(2):923–928, 2010.
  17. Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives. PLOS Computational Biology, 7(2):e1001076, 2011.
  18. K. T. D. Eames. The influence of school holiday timing on epidemic impact. Epidemiology and Infection, 142(9):1963–1971, 2014.
  19. Optimal, near-optimal, and robust epidemic control. Communications Physics, 4(1):1–8, 2021.
  20. Optimal control for a SIR epidemic model with limited quarantine. Scientific Reports, 12(1):12583, 2022.
  21. Synthesizing epidemiological and economic optima for control of immunizing infections. Proceedings of the National Academy of Sciences USA, 108(34):14366–14370, 2011.
  22. Vaccination strategies in structured populations under partial immunity and reinfection. Journal of Physics A: Mathematical and Theoretical, 56(20):204003, 2023.
  23. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science, 371(6532):916–921, 2021.
  24. Modelling the effect of a booster vaccination on disease epidemiology. Journal of Mathematical Biology, 52(3):290–306, 2006.
  25. Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination. Nature Communications, 12(1):3449, 2021.
  26. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. The Lancet Infectious Diseases, 21(6):793–802, 2021.
  27. Modeling the Effects of Vaccination and Treatment on Pandemic Influenza. The AAPS Journal, 13(3):427–437, 2011.
  28. Exploring optimal control strategies in seasonally varying flu-like epidemics. Journal of Theoretical Biology, 412:36–47, 2017.
  29. Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage. Vaccine, 37(44):6768–6775, 2019.
  30. Optimal timing of one-shot interventions for epidemic control. PLOS Computational Biology, 17(3):e1008763, 2021.
  31. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies. The Journal of Infectious Diseases, 217(5):731–741, 2018.
  32. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nature Reviews Immunology, 22(1):57–65, 2022.
  33. Analyzing the dynamics of an SIRS vaccination model with waning natural and vaccine-induced immunity. Nonlinear Analysis: Real World Applications, 12(5):2692–2705, 2011.
  34. Florian Nill. Endemic oscillations for SARS-CoV-2 Omicron—A SIRS model analysis. Chaos, Solitons & Fractals, 173:113678, 2023.
  35. Pulse mass measles vaccination across age cohorts. Proceedings of the National Academy of Sciences USA, 90(24):11698–11702, 1993.
  36. Implications of vaccination and waning immunity. Proceedings of the Royal Society B: Biological Sciences, 276(1664):2071–2080, 2009.
  37. Statistical physics of vaccination. Physics Reports, 664:1–113, 2016.
  38. Critical regimes driven by recurrent mobility patterns of reaction–diffusion processes in networks. Nature Physics, 14(4):391–395, 2018.
  39. Informe n.120. Situación de COVID-19 en España. Technical report, Red Nacional de Vigilancia Epidemiológica, 2022.
  40. COVID-19 Vaccine surveillance report. Report, UK Health Security Agency, 2022.
Citations (1)

Summary

Paper to Video (Beta)

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.